Features of the clinical course of uterine fibroids of reproductive age women

М. А. Флаксемберг
In: HEALTH OF WOMAN · 2018 · pp. 102–106 · doi:10.15574/hw.2018.132.102 · W3166894740
article OA: diamond CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-09 ⓘ

This study analyzed 250 reproductive-aged women with uterine fibroids, finding that inflammatory diseases, a history of abortion/miscarriage, endometrial pathology, adenomyosis, and pelvic adhesions were common comorbidities.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-03 · read from full text ⓘ

This study analyzed the clinical course and predictors of uterine fibroids in 250 reproductive-age women to develop tailored conservative and surgical treatment methods. The researchers examined anamnestic data, noting that the majority of patients were aged 26–40 with high educational attainment and histories of inflammatory genital diseases or adverse obstetric outcomes. Key findings revealed a high prevalence of concomitant endometrial pathology at 60.8%, alongside significant rates of adenomyosis at 34% and pelvic adhesions at 26.8%. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The objective: in this work represented part of materials of department rehabilitation of reproductive function for the examination and treatment of 250 patients with uterine fibrods in order to study and determine in detail the predictors of the disease, develop methods of treatment (conservative and surgical), as well as rehabilitation of the reproductive function, depending on the type and localization of the nodes. Materials and methods. The analysis of the anamnestic data, taking into account both objective and subjective data, analysis of anamnestic data of close relatives (maternal and paternal lines), concomitant genital and extragenital pathology is carried out. Results. The most numerical group of patients with uterine fibroids, according to our data, in the age groups of 26–35 years (32%) is 36–40 years (28.4%), which are the most socially and reproductively active. In this category, women with a high education of 33.6% and social status (30.4% and 22.4%) prevailed. The transferred inflammatory diseases of the genitals were noted in 48% of the examined, weighed gynecological anamnesis (abortions, miscarriages) were noted in 42.4%. Conclusion. Also for this category of patients is characterized by a high percentage of endometrial pathology – 60.8%, as well as concomitant adenomyosis – 34% and adhesion process of pelvic organs – 26.8%. Key words: clinical course, uterine fibroids, reproductive age.
Full text 4,482 characters · extracted from oa-html · 2 sections · click to expand

Materials

and methods. The analysis of the anamnestic data, taking into account both objective and subjective data, analysis of anamnestic data of close relatives (maternal and paternal lines), concomitant genital and extragenital pathology is carried out. Results. The most numerical group of patients with uterine fibroids, according to our data, in the age groups of 26–35 years (32%) is 36–40 years (28.4%), which are the most socially and reproductively active. In this category, women with a high education of 33.6% and social status (30.4% and 22.4%) prevailed. The transferred inflammatory diseases of the genitals were noted in 48% of the examined, weighed gynecological anamnesis (abortions, miscarriages) were noted in 42.4%. Conclusion. Also for this category of patients is characterized by a high percentage of endometrial pathology – 60.8%, as well as concomitant adenomyosis – 34% and adhesion process of pelvic organs – 26.8%. Key words: clinical course, uterine fibroids, reproductive age.

References

1. Kornatska AH, Raksha II, Kolesnichenko IS, Chubei HV. 2015. Suchasni pohliady na etiolohiiu, patohenez ta likuvannia leiomiomy matky u zhinok reproduktyvnoho viku (Ohliad literatury). Zdorove zhenshchіnу 1(97):10–12. 2. Kornatska AH, Kolesnichenko IS, Flaksemberh MA, Revenko OO. 2014. Osoblyvosti anatomo-funktsionalnoho stanu orhaniv maloho taza ta heneratyvnoi funktsii u zhinok z leiomiomoiu matky. Zdorove zhenshchіnу. K. 10(96):134–136. 3. Doherty L, Mutlu D, Sinclair D, Taylor H. 2014. Uterine fibroids: clinical manifestations and contemporary management. Reprod Sci. 21:1067–1092. https://doi.org/10.1177/1933719114533728; PMid:24819877 4. Wise LA, Laughlin-Tommaso SK. 2016, Mar. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clin. Obstet. Gynecol. 59(1):2–24. https://doi.org/10.1097/GRF.0000000000000164; PMid:26744813 PMCid:PMC4733579 5. Veropotvelyan PN, Veropotvelyan NP, Tsehsmistrenko IS, Bondarenko AA. 2016. Sovremennoe predstavlenie o miome matki i ee lechenii. Zdorove zhenschiny. K. 7(113):16–22. 6. Styer AK, Rueda BR. 2016, Jul. The Epidemiology and Genetics of Uterine Leiomyoma. Best Pract. Res. Clin. Obstet. Gynecol. 34:3. https://doi.org/10.1016/j.bpobgyn.2015.11.018; PMid:26725703 7. Hoida NH, Moiseienko RO, Maistruk HP. 2016. Osnovni dosiahnennia vykonannia Derzhavnoi prohramy «R» za 2005–2015 r. Zdorove zhenshchіnу 4:14–16. 8. Zhylka NIa. 2016. Innovatsiini pidkhody do likuvannia leiomiomy matky. Zdorove zhenshchinу. K. 7(113):104–106. 9. Sangkomkamhang US, Lumbiganon P, Laopaiboon M, Mol BW. 2013. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids. Cochrane Database Syst Rev. 2:CD008994. https://doi.org/10.1002/14651858.CD008994.pub2 10. Kulakov VI. 2014. Novyie podhodyi k lecheniyu miomyi matki. Mnenie eksperta. Problemy reproduktsii 2:57–58. 11. Yerushalmi GM, Gilboa Y, Jakobson-Setton A, Tadir Y, Goldch-mit C, Kats D, Seidman DS. 2014. Vaginal mifepristone for the treatment of symptomatic uterine leomyomata: an open-label study. Fertil Steril. 101:496–500. https://doi.org/10.1016/j.fertnstert.2013.10.015; PMid:24220703 12. Radzinskiy VE, Fatkulin IF, Bakanova AR, Dobretsova TA. 2014. Mioma matki: ot diskussiy k innovatsiyam. Prakticheskie rekomendatsii. M, Redaktsiya zhurnala Status Praesens:16. 13. Lebedev VA, Davyidov AI, Pashkov VM. 2013. Spornyie i nereshennyie voprosyi lecheniya i profilaktiki miomyi matki u bolnyih reproduktivnogo perioda. Trudnyiy patsient 11(8–9):14–19. 14. Zvyichaynyiy MA, Vorontsova AV, Chilova AL, Fedotovskih IV. 2014. Giperplasticheskiy sindrom reproduktivnoy sistemy u zhenschin v perimenopauze: taktika konservativnoy terapii i reabilitatsii. Ginekologiya 1:44–48.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK